For example, while BRAF inhibitors have shown to be effective in melanomas carrying BRAF mutations, they have demonstrated little effect in the treatment of BRAF mutant colon cancers [33, 55, 56]. This evidence concerns the gene BRAF and malignant colon neoplasm.